Parallax Volatility Advisers
DOVA

Parallax Volatility Advisers’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History

Parallax Volatility Advisers’s Portfolio DOVA Stock Details DOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-5,100
Closed -$45K – 4188
2019
Q1 		$45K Buy
+5,100
New +$41.4K ﹤0.01% 2361
2018
Q1 		– Sell
-756
Closed -$22K – 5054
2017
Q4 		$22K Buy
+756
New +$20.7K ﹤0.01% 3649

Other funds holding DOVA

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SMH
Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Parallax Volatility Advisers's DOVA Position: Q2 2019 in Review

Parallax Volatility Advisers sold out of Dova Pharmaceuticals, Inc. Common Stock (DOVA) in Q2 2019, closing a stake of 5,100 shares — an estimated $45K sold.

Parallax Volatility Advisers first reported a position in DOVA in Q4 2017 and held it in 2 quarters. The position peaked at $45K in Q1 2019. 66 funds tracked by Wall St. Rank hold DOVA as of Q2 2019.

  • Parallax Volatility Advisers reported no remaining Dova Pharmaceuticals, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • Parallax Volatility Advisers sold 5,100 Dova Pharmaceuticals, Inc. Common Stock shares in Q2 2019, an estimated $45K.
  • Parallax Volatility Advisers first reported a position in Dova Pharmaceuticals, Inc. Common Stock in Q4 2017 and held it in 2 quarters.
  • Parallax Volatility Advisers's Dova Pharmaceuticals, Inc. Common Stock position peaked at $45K in Q1 2019.
  • 66 funds tracked by Wall St. Rank held Dova Pharmaceuticals, Inc. Common Stock as of Q2 2019.

Based on Parallax Volatility Advisers's 13F filing for Q2 2019, filed 14 Aug 2019.